Consensus $24.80. Raises FY26 revenue view to $47.3B-$48.1B from $46.3B-$47.2B, consensus $47.7B. Says guidance raise reflects strong start to year and Clario acquisition. Says guidance assumes 3%-4% organic revenue growth and $300M tailwind to revenue from foreign exchange.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TMO:
- Thermo Fisher Scientific: Buy Rating Reiterated on Solid Core Growth and Emerging AI, Reshoring Catalysts
- Thermo Fisher reports Q1 adjusted EPS $5.44, consensus $5.24
- Notable companies reporting before tomorrow’s open
- Thermo Fisher Scientific (TMO) Q1 Earnings Cheat Sheet
- OpenAI Debuts GPT-Rosalind, Its First AI Model Built Exclusively for Scientists